BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21998340)

  • 21. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.
    Kavsak PA; MacRae AR; Newman AM; Lustig V; Palomaki GE; Ko DT; Tu JV; Jaffe AS
    Clin Chim Acta; 2007 May; 380(1-2):213-6. PubMed ID: 17306781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of the detection limit for lateral flow immunoassays: evaluation and comparison of bioconjugates.
    Linares EM; Kubota LT; Michaelis J; Thalhammer S
    J Immunol Methods; 2012 Jan; 375(1-2):264-70. PubMed ID: 22100215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasensitive dual-color rapid lateral flow immunoassay via gold nanoparticles with two different morphologies for the serodiagnosis of human brucellosis.
    Zhu M; Zhang J; Cao J; Ma J; Li X; Shi F
    Anal Bioanal Chem; 2019 Dec; 411(30):8033-8042. PubMed ID: 31781813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly Sensitive Chemiluminescence-Based Lateral Flow Immunoassay for Cardiac Troponin I Detection in Human Serum.
    Han GR; Kim MG
    Sensors (Basel); 2020 May; 20(9):. PubMed ID: 32370181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference.
    Savukoski T; Jacobino J; Laitinen P; Lindahl B; Venge P; Ristiniemi N; Wittfooth S; Pettersson K
    Clin Chem Lab Med; 2014 Jul; 52(7):1041-8. PubMed ID: 24615485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated, Universal, and Mass-Producible Paper-Based Lateral Flow Biosensing Platform for High-Performance Point-of-Care Testing.
    Han GR; Ki H; Kim MG
    ACS Appl Mater Interfaces; 2020 Jan; 12(1):1885-1894. PubMed ID: 31813220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid and sensitive cardiac troponin I immunoassay based on fluorescent europium(III)-chelate-dyed nanoparticles.
    Järvenpää ML; Kuningas K; Niemi I; Hedberg P; Ristiniemi N; Pettersson K; Lövgren T
    Clin Chim Acta; 2012 Dec; 414():70-5. PubMed ID: 22975206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiomyocyte injury induced by hemodynamic cardiac stress: Differential release of cardiac biomarkers.
    Irfan A; Reichlin T; Twerenbold R; Fischer C; Ballarino P; Nelles B; Wildi K; Zellweger C; Rubini Gimenez M; Mueller M; Haaf P; Fischer A; Freidank H; Osswald S; Mueller C
    Clin Biochem; 2015 Dec; 48(18):1225-9. PubMed ID: 26129882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrocomplexes and discordant high-sensitivity cardiac troponin concentrations.
    Kavsak PA; Roy C; Malinowski P; Mark CT; Scott T; Clark L; Lamers S; Ainsworth C
    Ann Clin Biochem; 2018 Jul; 55(4):500-504. PubMed ID: 28920468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical performance of time-resolved fluorometry-based Innotrac Aio! cardiac marker immunoassays.
    Hedberg P; Valkama J; Puukka M
    Scand J Clin Lab Invest; 2003; 63(1):55-64. PubMed ID: 12729070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separation-Free Electrogenerated Chemiluminescence Immunoassay Incorporating Target Assistant Proximity Hybridization and Dynamically Competitive Hybridization of a DNA Signal Probe.
    Wang B; Shi S; Yang X; Wang Y; Qi H; Gao Q; Zhang C
    Anal Chem; 2020 Jan; 92(1):884-891. PubMed ID: 31808341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of the troponin 99th percentile cut-off and clinical utility of myoglobin measurement in the early management of chest pain patients admitted to the Emergency Cardiology Department.
    Amodio G; Antonelli G; Varraso L; Ruggieri V; Di Serio F
    Coron Artery Dis; 2007 May; 18(3):181-6. PubMed ID: 17429291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a dual monoclonal solid phase and a polyclonal detector to create an immunoassay for the detection of human cardiac troponin I.
    Oh SK; Foster K; Datta P; Orswell M; Tasaico K; Mai X; Connolly P; Reamer R; Walsh R; Yang G; Barlow E; Bluestein B; Parsons G
    Clin Biochem; 2000 Jun; 33(4):255-62. PubMed ID: 10936582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A.
    Tanasijevic MJ; Cannon CP; Wybenga DR; Fischer GA; Grudzien C; Gibson CM; Winkelman JW; Antman EM; Braunwald E
    Am Heart J; 1997 Oct; 134(4):622-30. PubMed ID: 9351728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel integrated lateral flow immunoassay platform for the detection of cardiac troponin I using hierarchical dendritic copper-nickel nanostructures.
    Tan Y; Zhang S; Liu Y; Li J; Zhang S; Pan H
    Talanta; 2024 May; 277():126332. PubMed ID: 38823322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay.
    Lippi G; Ferrari A; Gandini G; Gelati M; Lo Cascio C; Salvagno GL
    Clin Chem Lab Med; 2017 Nov; 56(1):157-161. PubMed ID: 28704179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-pot synthesis of AuPt@Fe
    Wang H; Yao C; Fan J; He Y; Wang Z
    Biosens Bioelectron; 2023 Oct; 237():115508. PubMed ID: 37442031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of high sensitivity troponin T and I assays in the diagnosis of non-ST elevation acute myocardial infarction in emergency patients with chest pain.
    Cullen L; Aldous S; Than M; Greenslade JH; Tate JR; George PM; Hammett CJ; Richards AM; Ungerer JP; Troughton RW; Brown AF; Flaws DF; Lamanna A; Pemberton CJ; Florkowski C; Pretorius CJ; Chu K; Parsonage WA
    Clin Biochem; 2014 Apr; 47(6):321-6. PubMed ID: 24316100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
    Wilson SR; Sabatine MS; Braunwald E; Sloan S; Murphy SA; Morrow DA
    Am Heart J; 2009 Sep; 158(3):386-91. PubMed ID: 19699861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular disease testing on the Dimension Vista system: biomarkers of acute coronary syndromes.
    Kelley WE; Lockwood CM; Cervelli DR; Sterner J; Scott MG; Duh SH; Christenson RH
    Clin Biochem; 2009 Sep; 42(13-14):1444-51. PubMed ID: 19523464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.